Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients

NCT00965549 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

463

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: INSULIN GLARGINE (HOE901)
DRUG: Insulin aspart
DRUG: Insulin Glulisine

Sponsor

Sanofi